Jasinski Lawrence J 4

4 · LEMAITRE VASCULAR INC · Filed Mar 30, 2026

AI-generated summary of this filing

Updated Mar 30, 2026

Lemaitre Vascular (LMAT) Director Jasinski Receives Awards

What Happened

Lawrence J. Jasinski, a director of Lemaitre Vascular, was credited with a total of 3.445 dividend-equivalent rights on March 26, 2026. The filing lists five derivative acquisitions (0.394, 0.472, 0.643, 0.728 and 1.208 shares) reported as awards/grants at $0.00 each (total reported value $0).
These items are dividend equivalent rights (DERs) tied to previously granted restricted stock units (RSUs) and performance share units (PSUs); they accrue and vest proportionately with those awards rather than representing an open-market purchase or sale.

Key Details

Transaction date: 2026-03-26; Form 4 filed: 2026-03-30 (filing appears within the standard two-business-day window).
Reported items: five derivative award entries totaling 3.445 shares; price per unit $0.00; total reported cash value $0.
Footnotes indicate the DERs relate to awards granted on 12/8/2023, 12/6/2024 and 12/10/2025 (combination of RSUs and PSUs; each DER equals the economic equivalent of one common share).
Shares owned after the transaction: not specified in the provided filing.

Context

These are not open-market purchases or sales — they are dividend-equivalent credits tied to existing equity awards and typically reflect accruals that convert into shares (or cash) as the underlying awards vest.
Such dividend-equivalent accruals are common and do not by themselves indicate a buy/sell signal; they simply record the allocation of small fractional share equivalents to the insider.

Form 4

Period: 2026-03-26

Director

Transactions

Award
Dividend Equivalent Rights
[F1]
2026-03-26+0.394→ 4.602 total
→ Common Stock (0.394 underlying)
Award
Dividend Equivalent Rights
[F2]
2026-03-26+0.472→ 4.311 total
→ Common Stock (0.472 underlying)
Award
Dividend Equivalent Rights
[F3]
2026-03-26+0.643→ 3.539 total
→ Common Stock (0.643 underlying)
Award
Dividend Equivalent Rights
[F4]
2026-03-26+0.728→ 3.624 total
→ Common Stock (0.728 underlying)
Award
Dividend Equivalent Rights
[F5]
2026-03-26+1.208→ 1.208 total
→ Common Stock (1.208 underlying)

Footnotes (5)

[F1]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F2]These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F3]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F4]These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F5]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Signature

/s/ Laurie A. Churchill, Attorney-in-fact|2026-03-30

1 file